HALOZYME REAFFIRMS IT PROJECTS ZERO TO MINIMAL IMPACT TO ROYALTY REVENUE THROUGH AT LEAST 2035 BASED ON MEDICARE DRUG PRICE NEGOTIATION PROGRAM FINAL RULE FOR IPAY 2029

Reuters · 3d ago

Please log in to view news